ORIGINAL RESEARCH article
Front. Oncol.
Sec. Gastrointestinal Cancers: Gastric and Esophageal Cancers
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1639531
Clinicopathological Characteristics and Clinical Outcomes of Remnant Gastric Cancer with Endoscopic Submucosal Dissection
Provisionally accepted
- Beijing Cancer Hospital, Beijing, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Remnant gastric cancer is distinct from primary gastric cancer clinically and pathologically. Recently, endoscopic submucosal dissection, widely used for treating early gastric cancer, has also been used to treat remnant gastric cancer. However, owing to the previous surgeries, endoscopic resection of remnant gastric cancer is more complicated. This study aimed to elucidate the clinicopathological characteristics of remnant gastric cancer and evaluate clinical outcomes of endoscopic submucosal dissection for this condition. Methods: This retrospective study examined the clinicopathological characteristics and clinical outcomes in 30 patients (32 lesions) with remnant gastric cancer who underwent endoscopic submucosal dissection from 2012 to 2023 at the Endoscopy Center of Peking University Cancer Hospital, China. Results: The primary disease was a malignant tumor in 25 patients and a benign tumor in 4. Billroth II was the major reconstruction method used in the initial surgery. The median interval from previous surgery to remnant gastric cancer detection was 4.2 years. The mean endoscopic submucosal dissection time was 136±71 min. The en bloc, R0, and curative resection rates were 96.9%, 78.1%, and 71.9%, respectively. While one patient had a perforation during the procedure, none experienced delayed postoperative bleeding. Two patients had local recurrence, and five died during the follow-up. The 5-year overall survival rate was 83.0%. This is a provisional file, not the final typeset article Conclusions: Remnant gastric cancer development is influenced by the type of initial disease and prior surgery. Endoscopic submucosal dissection is a safe and effective treatment for early remnant gastric cancer, with potential applicability for certain non-early-stage lesions. However, being technically challenging, endoscopic submucosal dissection requires the skills of experienced endoscopists and careful evaluation.
Keywords: Endoscopic Submucosal Dissection, Gastrectomy, Gastric Stump, remnant gastriccancer, en bloc resection
Received: 02 Jun 2025; Accepted: 08 Sep 2025.
Copyright: © 2025 Xiangyu, Wang, Li and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Qi Wu, Beijing Cancer Hospital, Beijing, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.